Mehdi Razavi, MD

Dr. Razavi is involved with numerous clinical trials assessing the efficacy of cutting edge technology in the field of cardiac electrophysiology. He has founded multiple medical device startups including: Saranas, a smart cardiology sheath, and Nanolinea, conductive nanotechnology for the treatment of arrhythmia. Additionally, Dr. Razavi has supervised the development of a number of technologies in collaboration with Rice University and Texas A&M and has over 20 patents to his name.

See Publications


  • Medical School:

    Medical College Of Pennsylvania

  • Residency:

    Mayo Graduate School of Medicine

  • Fellowships:

    Mayo Graduate School of Medicine


  • American Board of Internal Medicine, Cardiology (2001, 2011)
  • American Board of Internal Medicine, Clinical Cardiology Electrophysiology (2002, 2012)


Recent News

A Collaborative Spirit Gives Birth to an Ingenious Device

TMC News Innovation Issue highlights the true spirit of collaboration at the Texas Heart Institute. Read “The Early Bird Bleed...

Clinical Trial Results Show Promise for Device Invented at Texas Heart Institute

New results from a clinical trial testing a device invented at the Texas Heart Institute were presented at The Society...

Texas Heart Institute Invention Receives FDA Clearance

A new device invented by Texas Heart Institute (THI) became the first and only device to be cleared by the FDA for early...